Prostate Cancer Trial, Recruiting (NCT06535802)

Prostate Cancer Trial, Recruiting NCT06535802 Sponsor: Mayo Clinic Condition: Prostate Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06535802 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Prostate Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Consumer advocates who are part of a group called the iCCaRE Consortium
Clinicians (healthcare professionals) who are part of a program called Translational Research & Clinical Intervention Services (TRaCIS)
Certain iCCaRE consumer advocates taking part in early testing phases (including members of a Community Advisory Board and non-members)
Men who identify as African American or Black
People who have been diagnosed with prostate cancer in Florida at any point in their life, and/or who have had an abnormal prostate-related test result (either a PSA blood test or a Digital Rectal Examination) within the past 6 months
People who are at least 30 years old
People who are willing to give their consent to take part in the study

Who may not be able to join:

People who do not identify as African American or Black males
People who have not been diagnosed with prostate cancer in Florida at any point in their life, or who have not had an abnormal prostate-related test result (PSA blood test or Digital Rectal Examination) in the past 6 months
People who are older than 80 years old
People who are not willing to give their consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 7 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06535802

Sponsor: Mayo Clinic

Phase: Not Applicable

Status: Recruiting

Condition: Prostate Cancer

More information: https://clinicaltrials.gov/study/NCT06535802

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Consumer advocates who are part of a group called the iCCaRE Consortium
Clinicians (healthcare professionals) who are part of a program called Translational Research & Clinical Intervention Services (TRaCIS)
Certain iCCaRE consumer advocates taking part in early testing phases (including members of a Community Advisory Board and non-members)
Men who identify as African American or Black
People who have been diagnosed with prostate cancer in Florida at any point in their life, and/or who have had an abnormal prostate-related test result (either a PSA blood test or a Digital Rectal Examination) within the past 6 months
People who are at least 30 years old
People who are willing to give their consent to take part in the study

Who may not be able to join:

People who do not identify as African American or Black males
People who have not been diagnosed with prostate cancer in Florida at any point in their life, or who have not had an abnormal prostate-related test result (PSA blood test or Digital Rectal Examination) in the past 6 months
People who are older than 80 years old
People who are not willing to give their consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 7 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Mayo Clinic

Registry

ClinicalTrials.gov

Start date

20 November 2023

Est. completion

1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Point of Prostate Cancer Diagnosis (PPCD) iCCaRE Virtual Reality Assistant (ViRA) model; Acceptance of the iCCaRE ViRA; Usability of the iCCaRE ViRA

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov